In a new study on mice, an experimental antibody treatment reduced the lingering after-effects of head injuries.
A study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By studying the effects of the nasal anti-CD3 in a mouse model of TBI,
A treatment tested by researchers in Boston found it improves motor function, coordination and spatial memory in mice. But it still must pass human trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback